INITIATIVES

Description:

Ventilator-associated pneumonia (VAP) is a type of hospital-acquired infection that typically develops after more than 48 hours of mechanical ventilation. VAP is a common and serious problem in the intensive care unit that is associated with an increased risk of death.  Additionally, VAP significantly contributes to additional healthcare costs, mainly associated to longer ICU and hospital stay. This webinar will address the best practices for preventing VAP and exam the barriers to implementation

 

Learning Objectives:

Upon completion of this educational activity, the participant will be able to:

1. Discuss the scope of the problem and current evidence 

2. Describe the role of subglottic secretions in the pathogenesis of VAP

3. Discuss the mechanisms of barriers to implementation of best practices in the prevention of VAP 

 

Faculty

Ashish K. Khanna MD, FCCP,  FCCM  is an associate professor of anesthesiology at the Wake Forest School of Medicine, and an anesthesiologist/intensivist at the Wake Forest Baptist Medical Center, Winston-Salem, NC. He serves on several editorial boards including the Journal of Critical Care and the Annals of Intensive Care.  Dr. Khanna has published extensively in peer-reviewed journals on several perioperative topics including opioid-related respiratory complications, and the prediction of and monitoring for cardiorespiratory complications within and outside the ICU.